Purified Anti-Human CD47 Antibody[CC2C6D4]

Introducing the Purified Anti-Human CD47 Antibody [CC2C6D4], a highly effective and reliable solution for targeted immunotherapy. This antibody has been specifically designed to target the CD47 protein, which is known to be overexpressed in various types of cancer cells. The antibody has undergone rigorous purification processes to ensure its purity and potency, making it an ideal choice for use in research and clinical applications.

The Purified Anti-Human CD47 Antibody [CC2C6D4] has been extensively tested for its specificity and efficacy, and has demonstrated exceptional results in preclinical studies. Its high affinity for the CD47 protein ensures that it can effectively block the "don't eat me" signal that cancer cells use to evade the immune system, thereby promoting phagocytosis and enhancing the body's natural defense mechanisms against cancer.

This antibody is available in various formats, including purified, conjugated, and biotinylated, to suit different experimental needs. Its exceptional quality and reliability make it an indispensable tool for researchers and clinicians alike, who seek to advance the field of cancer immunotherapy.

In summary, the Purified Anti-Human CD47 Antibody [CC2C6D4] is a highly purified and potent solution for targeted immunotherapy, with exceptional specificity and efficacy. Its availability in various formats makes it a versatile tool for research and clinical applications, and its proven track record in preclinical studies makes it a promising candidate for future cancer therapies.